Wei-Jong Shia, Ph.D. - Publications

Affiliations: 
2006 Pennsylvania State University, State College, PA, United States 
Area:
Molecular Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Brin E, Wu K, He Y, Shia W, Kuo MM, Chen L, Dagostino E, Hickey R, Almassy B, Showalter R, Thomson J. Abstract 3902: A novel biologic ADI-TRAIL fusion protein benefits from structural and functional complementarity of its components arginine deiminase and TRAIL, induces cancer cell apoptosis in vitro, and inhibits tumor growth in vivo Cancer Research. 78: 3902-3902. DOI: 10.1158/1538-7445.Am2018-3902  0.316
2013 DeKelver RC, Yan M, Ahn EY, Shia WJ, Speck NA, Zhang DE. Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood. 121: 3714-7. PMID 23426948 DOI: 10.1182/Blood-2012-11-465641  0.376
2013 Ahn EE, Higashi T, Yan M, Matsuura S, Hickey CJ, Lo MC, Shia WJ, DeKelver RC, Zhang DE. SON protein regulates GATA-2 through transcriptional control of the microRNA 23a~27a~24-2 cluster. The Journal of Biological Chemistry. 288: 5381-8. PMID 23322776 DOI: 10.1074/Jbc.M112.447227  0.341
2012 Lo MC, Peterson LF, Yan M, Cong X, Jin F, Shia WJ, Matsuura S, Ahn EY, Komeno Y, Ly M, Ommen HB, Chen IM, Hokland P, Willman CL, Ren B, et al. Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML. Blood. 120: 1473-84. PMID 22740448 DOI: 10.1182/Blood-2011-12-395335  0.321
2012 Shia WJ, Okumura AJ, Yan M, Sarkeshik A, Lo MC, Matsuura S, Komeno Y, Zhao X, Nimer SD, Yates JR, Zhang DE. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood. 119: 4953-62. PMID 22498736 DOI: 10.1182/blood-2011-04-347476  0.4
2012 Ahn E, Higashi T, Yan M, Matsuura S, Lo M, Shia W, Dekelver R, Zhang D. SON Regulates GATA-2 Through Transcriptional Control of the Mir-23a∼27a∼24-2 Cluster Blood. 120: 110-110. DOI: 10.1182/Blood.V120.21.110.110  0.31
2006 Shia WJ, Li B, Workman JL. SAS-mediated acetylation of histone H4 Lys 16 is required for H2A.Z incorporation at subtelomeric regions in Saccharomyces cerevisiae. Genes & Development. 20: 2507-12. PMID 16980580 DOI: 10.1101/Gad.1439206  0.583
2006 Shia WJ, Pattenden SG, Workman JL. Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biology. 7: 217. PMID 16689998 DOI: 10.1186/Gb-2006-7-5-217  0.576
2005 Carrozza MJ, Florens L, Swanson SK, Shia WJ, Anderson S, Yates J, Washburn MP, Workman JL. Stable incorporation of sequence specific repressors Ash1 and Ume6 into the Rpd3L complex. Biochimica Et Biophysica Acta. 1731: 77-87; discussion 75. PMID 16314178 DOI: 10.1016/J.Bbaexp.2005.09.005  0.584
2005 Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson S, Yates J, Washburn MP, Workman JL. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell. 123: 581-92. PMID 16286007 DOI: 10.1016/J.Cell.2005.10.023  0.605
2005 Shia WJ, Osada S, Florens L, Swanson SK, Washburn MP, Workman JL. Characterization of the yeast trimeric-SAS acetyltransferase complex. The Journal of Biological Chemistry. 280: 11987-94. PMID 15659401 DOI: 10.1074/Jbc.M500276200  0.638
2003 Sutton A, Shia WJ, Band D, Kaufman PD, Osada S, Workman JL, Sternglanz R. Sas4 and Sas5 are required for the histone acetyltransferase activity of Sas2 in the SAS complex. The Journal of Biological Chemistry. 278: 16887-92. PMID 12626510 DOI: 10.1074/Jbc.M210709200  0.638
2000 Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, Wu CW. Histone deacetylases specifically down-regulate p53-dependent gene activation Journal of Biological Chemistry. 275: 20436-20443. PMID 10777477 DOI: 10.1074/Jbc.M000202200  0.559
Show low-probability matches.